Karine Mari

717 total citations · 1 hit paper
16 papers, 415 citations indexed

About

Karine Mari is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Agronomy and Crop Science. According to data from OpenAlex, Karine Mari has authored 16 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Agronomy and Crop Science. Recurrent topics in Karine Mari's work include Respiratory viral infections research (8 papers), Pneumonia and Respiratory Infections (6 papers) and Virus-based gene therapy research (3 papers). Karine Mari is often cited by papers focused on Respiratory viral infections research (8 papers), Pneumonia and Respiratory Infections (6 papers) and Virus-based gene therapy research (3 papers). Karine Mari collaborates with scholars based in France, United States and Singapore. Karine Mari's co-authors include Laurence Maynard, Hyone‐Myong Eun, Didier Pinquier, Jing Jin, Friedrich W. Kaiser, Katrina Cathie, Mathieu Bangert, Simon B. Drysdale, Helen Hill and Pierre Tissières and has published in prestigious journals such as New England Journal of Medicine, PEDIATRICS and Clinical Microbiology and Infection.

In The Last Decade

Karine Mari

16 papers receiving 400 citations

Hit Papers

Nirsevimab for Prevention of Hospitalizations Due to RSV ... 2023 2026 2024 2025 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karine Mari France 10 255 100 91 89 47 16 415
Matthew Donati United Kingdom 16 520 2.0× 36 0.4× 153 1.7× 22 0.2× 70 1.5× 31 665
Stephanie Jones South Africa 14 499 2.0× 51 0.5× 218 2.4× 48 0.5× 96 2.0× 23 779
Monika Redlberger‐Fritz Austria 15 480 1.9× 91 0.9× 245 2.7× 19 0.2× 84 1.8× 44 655
Barbara Biere Germany 14 536 2.1× 101 1.0× 272 3.0× 45 0.5× 25 0.5× 33 680
María Florencia Delgado Argentina 7 464 1.8× 186 1.9× 227 2.5× 27 0.3× 143 3.0× 10 607
Tyler Bristol United States 9 597 2.3× 51 0.5× 262 2.9× 30 0.3× 169 3.6× 12 785
Sara Martin United States 8 160 0.6× 67 0.7× 18 0.2× 48 0.5× 129 2.7× 11 373
Stephan Bart United States 11 303 1.2× 46 0.5× 222 2.4× 26 0.3× 69 1.5× 19 438
Meri Gorgievski-Hrisoho Switzerland 13 338 1.3× 124 1.2× 196 2.2× 18 0.2× 22 0.5× 23 543

Countries citing papers authored by Karine Mari

Since Specialization
Citations

This map shows the geographic impact of Karine Mari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karine Mari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karine Mari more than expected).

Fields of papers citing papers by Karine Mari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karine Mari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karine Mari. The network helps show where Karine Mari may publish in the future.

Co-authorship network of co-authors of Karine Mari

This figure shows the co-authorship network connecting the top 25 collaborators of Karine Mari. A scholar is included among the top collaborators of Karine Mari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karine Mari. Karine Mari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Munro, Alasdair, Simon B. Drysdale, Katrina Cathie, et al.. (2025). 180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial. The Lancet Child & Adolescent Health. 9(6). 404–412. 10 indexed citations
2.
Levy, Corinne, Romain Basmaci, Karine Levieux, et al.. (2025). Nirsevimab effectiveness on paediatric emergency visits for RSV bronchiolitis: a test-negative design study. European Journal of Pediatrics. 184(2). 171–171. 6 indexed citations
3.
Hsiao, Amber, John Hansen, Bruce Fireman, et al.. (2025). Effectiveness of Nirsevimab Against RSV and RSV-Related Events in Infants. PEDIATRICS. 156(2). 3 indexed citations
5.
Palmu, Arto A., Stéphanie Pépin, Ritva Syrjänen, et al.. (2024). High‐Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults. Influenza and Other Respiratory Viruses. 18(4). e13270–e13270. 5 indexed citations
6.
Hansen, John, Julius Timbol, Bruce Fireman, et al.. (2024). Effectiveness of nirsevimab in infants against respiratory syncytial virus and related events. Annals of Allergy Asthma & Immunology. 133(6). S3–S4. 1 indexed citations
7.
Drysdale, Simon B., Katrina Cathie, Florence Flamein, et al.. (2023). Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants. New England Journal of Medicine. 389(26). 2425–2435. 175 indexed citations breakdown →
8.
Montoya, Ana, Rocío Checa, Valentina Marino, et al.. (2021). Antibodies elicited by the CaniLeish® vaccine: long-term clinical follow-up study of dogs in Spain. Parasitology Research. 120(4). 1471–1479. 5 indexed citations
9.
Franc, Sylvia, Michaël Joubert, C. Fagour, et al.. (2019). Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab‐2 randomized controlled trial. Diabetes Obesity and Metabolism. 21(10). 2327–2332. 23 indexed citations
10.
Liu, Joyce F., Jungmin Lee, Ellie S. Strock, et al.. (2018). Technology Applications: Use of Digital Health Technology to Enable Drug Development. JCO Clinical Cancer Informatics. 2(2). 1–12. 14 indexed citations
11.
Ochs, Martina M., Anthony Sheung, Lucian Visan, et al.. (2016). A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge. Human Vaccines & Immunotherapeutics. 12(11). 2946–2952. 11 indexed citations
12.
Cheung, Peter, Karine Mari, Valérie Devauchelle‐Pensec, et al.. (2016). Predictive value of tender joints compared to synovitis for structural damage in rheumatoid arthritis. RMD Open. 2(1). e000205–e000205. 13 indexed citations
13.
14.
15.
Mari, Karine, et al.. (2003). Treatment of canine parvoviral enteritis with interferon‐omega in a placebo‐controlled field trial. Veterinary Record. 152(4). 105–108. 59 indexed citations
16.
Ponsart, Claire, M. Nibart, Marjorie Durand, et al.. (2002). Influence of CIDR treatment during superovulation on embryo production and hormonal patterns in cattle. Theriogenology. 58(6). 1141–1151. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026